Mainz Biomed Nv

Penny Stocks Biotech Stocks Healthcare Stocks

$0.95

-0.04 (-4.51%)

As of Feb 8, 2:29 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,852.2% upside

Low Target $22.75

Average Target $27.91

High Target $44.33

Current Price $0.95

Current
$0.95

Target
$27.91

$22.75 $27.91 avg $44.33

Scenario Analysis

Bear Case

$22.75

2,306.4%

Low target

Base Case

$27.91

+2,852.2%

Avg target

Bull Case

$44.33

+4,589.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$28.27

-96.7% from high

52-Week Low

$13.34

+-92.9% from low

Target vs 52W High

$27.91

-1.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%